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Abstract: Endobroncheal tuberculosis is defined as tuberculous infection of the tracheobronchial tree with microbial and 
histopathological evidence. The disease is usually mistaken for other lung diseases including lung cancer. Bronchial stenosis is 
a common complication of this type of tuberculosis despite the use of effective anti-tuberculous chemotherapy. We are 
presenting a case of endobronchial tuberculosis that simulated lung cancer and healed without residual bronchial stenosis. 
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Introduction 
Endobronchial tuberculosis (EBTB) is a form of 
tuberculous infection that involves mainly the trachea 
and/or bronchi. The disease is often mistaken for more 
common lung diseases like pneumonia, asthma, lung 
cancer and other lung diseases. Endobronchial stenosis is 
a common complication of EBTB despite the use of anti-
tuberculous chemotherapy. We are presenting a case of 
EBTB that manifested with two endobronchial masses, 
which almost totally occluded the bronchial lumen and 
resulted in repeated episodes of post-obstructive 
pneumonia for more than a year prior to diagnosis. Our 
patient was successfully treated with anti-tuberculous 
chemotherapy without the use of corticosteroids. 
Repeated bronchoscopic examination after six months 
from initiating antituberculous treatment revealed 
complete resolution of the two lesions without residual 
bronchial stenosis. 
Case presentation 
A 62 year old Pakistani woman was admitted to Hamad 
General Hospital with history of fever for 10 days prior to 
admission. She denied any history of cough, hemoptysis, 
breathlessness, chest pain, nocturnal sweating or weight 
loss. Prior to admission she was prescribed a seven-day 
course of amoxicillin that was changed to cephalexin by 
her family physician without improvement. For more than 
a year prior to this admission she had frequent visits to 
emergency room and a hospital admission for recurrent 
episodes of fever and cough that were diagnosed as 
community acquired pneumonia based on the radiographic 
finding of right lung opacity and the response to antibiotic 
therapy. Three years earlier she was admitted for 
abdominal surgery due to a perforated duodenal ulcer and 
incidentally discovered to have type 2 diabetes for which 
she was commenced on glibenclamide. She had frequent 
visits to Pakistan, the last of which was 2 years prior to 
her admission. Eight months prior to her admission she 
was refused entry to Canada because of abnormal Chest 
radiograph. She was a housewife, life-long non-smoker, 
and never consumed alcohol. She never kept pets or birds. 
 
Physical examination was remarkable for fever of 39.5 
Cº and dull percussion note over the right lower and mid 
chest, without added sounds. 
 
Laboratory investigations at admission revealed 
leucopenia of 1.8 X 103/ul with neutropenia of 0.5 X 
103/ul and normal hemoglobin and platelet count. 
Erythrocyte sedimentation rate (ESR) was 105 /hr. 
Peripheral blood smear revealed marked leucopenia with 
severe neutropenia, few toxic, left-shifted neutrophils and 
reactive lymphocytes without malarial parasites seen 
(picture of severe infection or drug induced cytopenia). 
Two samples for blood culture and urine culture did not 
grow bacteria or fungi. Tuberculin skin test was 14 mm at 
72 hours. Bacterial culture of the sputum, 3 sputum 
samples for acid-fast bacilli smear and culture and Human 
Immunodeficiency Virus (HIV) testing were all negative. 
 
Chest radiograph revealed right lower and mid zone 
non-homogenous opacity (Figure 1). Computerized 
tomography (CT scan) of the chest and abdomen revealed 
a soft tissue enhancing mass in the lumen of the right 
main bronchus that was associated with distal 
parnechymal consolidation and multiple lymph node 
enlargement (Figure 2). 
 
Bone marrow examination revealed a cellular marrow 
without evidence of involvement by neoplastic or 
granulomatous process. 
 
Bronchoscopy was done and showed two large 
endobronchial masses, one in the right main bronchus and 
the other in the right upper lobe bronchus with glistening, 
whitish surface (Figure 3). Endobronchial biopsy was 
taken from both masses and reveled caseating granuloma 
with presence of acid-fast bacilli on Zeihl-Nelsen staining 
(Figure 4). 
 
Bronchoalveolar lavage culture for acid-fast bacilli was 
negative. The patient was diagnosed as tumorous type 
EBTB causing post-obstructive pneumonia. Her leucopenia 
was attributed to antibiotics prescribed by her family 
physician. She was started on intravenous meropenem for 
14 days and antituberculous chemotherapy in the form of 
Rifampicin, Isoniazide, Ethambutol and Pyrazinamide for 2 
months, and then continued on Rifampicin and Isoniazide 
for further 4 months. No corticosteroid therapy was used 
at any stage of the treatment. 
 
The patient made a good recovery and was discharged 
home in a good condition. A repeated bronchoscopy 6 
months later revealed complete resolution of the 
endobronchial masses without evidence of bronchial 
stenosis (Figure 5). 
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Figure 1: Chest radiograph showing opacification of the right 
lower zone 
 
 
Figure 2: CT scan of the chest showing right bronchial mass with 
post-obstructive consolidation (arrows) 
 
Discussion
EBTB was first described by the English physician 
Richard Morten in 1698 [1]. The disease remained 
infrequently reported and was mainly a postmortem 
pathological diagnosis until the advent of bronchoscopy in 
the late 1920s [2]. EBTB is defined as tuberculous 
infection of the tracheobronchial tree with microbial and 
histopathological evidence [3,4].  
 
This form of tuberculous infection continues to be an 
important health problem for three reasons; firstly, its 
diagnosis is frequently delayed, particularly in developed 
countries, as the decreased incidence itself diminishes the 
suspicion of tuberculosis. Secondly, bronchial stenosis is a 
serious complication of the disease that may develop 
despite efficacious antituberculous chemotherapy and 
thirdly, it is often misdiagnosed as bronchial asthma or 
lung cancer [5,6,7]. 
 
  
 
Figure 3: Bronchoscopic picture showing a mass in the right main 
bronchus and another one in the right upper lobe bronchus 
  
 
Figure 4: Histopathologic slides showing caseating granuloma 
with acid-fast bacilli (arrow) 
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Figure 5: Bronchoscopic picture of the right main bronchus and 
the right upper lobe bronchus after six months of treatment 
showing disappearance of the masses with no residual stenosis  
 
The exact pathogenesis of EBTB is unknown, however, 
direct extension from adjacent pulmonary parenchymal 
lesion, implantation of the organisms from infected 
sputum, dissemination from the blood or erosion of a 
lymph node into the bronchus have all been suggested as 
possible mechanisms of the disease [3,8]. Chung and Lee 
identified seven subtypes of EBTB on bronchoscopic 
appearance [5]; the actively caseating type (43.0%), the 
edematous-hyperemic type (14.0%), the fibrostenotic type 
(10.5%), the tumorous type (10.5%), the granular type 
(11.4%), the ulcerative type (2.7%), and the non-specific 
bronchitic type (7.9%). Among these subtypes, the 
prognosis of tumorous EBTB was found to be most grave 
and unpredictable. The majority of the tumorous EBTB 
cases studied by Chung and Lee changed to fibrostenotic 
type within 3 months of treatment. Tumorous EBTB is 
characterized by an endobronchial mass whose surface is 
covered by caseous material and totally or near totally 
occludes the bronchial lumen. This form of EBTB is 
frequently mistaken for lung cancer, adenoma or carcinoid 
tumors. 
 
The two most important goals when treating EBTB are 
to eradicate tubercle bacilli and to prevent bronchial 
stenosis. Although anti-tuberculous chemotherapy is 
effective in controlling infection, it does not prevent 
residual bronchostenosis [5,4]. Oral corticosteroids have 
been used empirically to prevent bronchial stenosis, 
nevertheless, their role remains uncertain and 
controversial [9,10]. Many patients with EBTB will require 
aggressive treatment like repeated dilatation, the use of 
stents or even resection to treat bronchial stenosis [11]. 
Some previous studies have suggested that delay in 
diagnosis of EBTB is an independent predictor of the 
development of persistent airway stenosis [12]. 
 
Our patient presented with two tumorous growths that 
almost completely obstructed the lumens of the right main 
bronchus and right upper lobe bronchus and resulted in 
recurrent episodes of post-obstructive pneumonia for 
more than a year prior to diagnosis. Considering the 
prognosis of tumorous type EBTB and the delay in 
diagnosis as a predictor for the development of bronchial 
stenosis, healing without stenosis in our case seems 
interesting. It may suggest that the exact mechanism 
behind the tendency of some patients and certain types of 
EBTB to develop bronchial stenosis is not yet completely 
understood. Future research should focus on the 
pathogenesis of bronchial inflammatory reaction induced 
by EBTB in order to understand this mechanism.   
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